← Return to Clinical Trials: they are not designed only to be a “last resort”
DiscussionClinical Trials: they are not designed only to be a “last resort”
Pancreatic Cancer | Last Active: Sep 13 7:47am | Replies (42)Comment receiving replies
Replies to "Your situation may even be simpler. Physicians can prescribe a medication approved for another use as..."
You're a weath of information, sir. I'm feeling more assured that if I'm still here in June of '26, the end of my NIH trial, I'll be able to continue using the Olaparib. And if anyone reading this forum has pancreatic acinar cell cancer, and also has the BRCA2 mutation, the clinical trial I'm in is still looking for participants. They are looking for 20 patients but so far I'm the only one in the trial. The NIH protocol title for the trial is "000596-C: Phase II study of Olaparib in subjects with advanced Pancreatic Acinar Cell Carcinoma". The contact doctor is Christine Alewine. I don't have her ph. no. handy. I was concerned that, since this study is government funded, they might pull the plug on it due to lack of participants. Dr. Alewine said, "That's not going to happen." I'm hoping some others come forward.